Abstract

As an intracellular pathogen, the reproduction of the hepatitis B virus (HBV) depends on the occupancy of host metabolism machinery. Here we test a hypothesis if HBV may govern intracellular biosynthesis to achieve a productive reproduction. To test this hypothesis, we set up an affinity purification screen for host factors that interact with large viral surface antigens (LHBS). This identified pyruvate kinase isoform M2 (PKM2), a key regulator of glucose metabolism, as a binding partner of viral surface antigens. We showed that the expression of viral LHBS affected oligomerization of PKM2 in hepatocytes, thereby increasing glucose consumption and lactate production, a phenomenon known as aerobic glycolysis. Reduction of PKM2 activity was also validated in several different models, including HBV-infected HepG2-NTCP-C4 cells, adenovirus mediated HBV gene transduction and transfection with a plasmid containing complete HBV genome on HuH-7 cells. We found the recovery of PKM2 activity in hepatocytes by chemical activators, TEPP-46 or DASA-58, reduced expressions of viral surface and core antigens. In addition, reduction of glycolysis by culturing in low-glucose condition or treatment with 2-deoxyglucose also decreased expressions of viral surface antigen, without affecting general host proteins. Finally, TEPP-46 largely suppressed proliferation of LHBS-positive cells on 3-dimensional agarose plates, but showed no effect on the traditional 2-dimensional cell culture. Taken together, these results indicate that HBV-induced metabolic switch may support its own translation in hepatocytes. In addition, aerobic glycolysis is likely essential for LHBS-mediated oncogenesis. Accordingly, restriction of glucose metabolism may be considered as a novel strategy to restrain viral protein synthesis and subsequent oncogenesis during chronic HBV infection.

Highlights

  • Hepatitis B is a life-threatening infectious liver disease caused by the hepatitis B virus (HBV)

  • This virus-host interaction induces metabolic switch from oxidative phosphorylation to aerobic glycolysis, with increased glucose consumption and lactate production. We show that such metabolic switch favors viral protein synthesis and contributes hepatocarcinogenesis

  • This study highlights the importance of host metabolism in supporting viral protein synthesis and indicates a novel therapeutic approach to control chronic HBV infection via modulating host metabolic switch

Read more

Summary

Introduction

Hepatitis B is a life-threatening infectious liver disease caused by the hepatitis B virus (HBV). Chronic HBV infection affects ~292 million people worldwide (63.8% in Asia and 27.6% in Africa) in 2016, and has potential adverse outcomes that include hepatic decompensation, cirrhosis and/or hepatocellular carcinoma (HCC) [1]. WHO reported that 27 million people (10.5% of all people estimated to be living with chronic hepatitis B) were aware of their infection, while 4.5 million (16.7%) of the people diagnosed were on treatment Though the currently available antiviral drugs can effectively reduce serum viral load in patients with chronic hepatitis B, complete elimination of the virus in the liver is still difficult. The blame goes to the long-lasting nature of an intracellular viral replication intermediate termed covalently closed circular (ccc) DNA, which serves as a viral persistence reservoir in the liver [2]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.